Potassium channel blockers: all 156 studies that test it

Page 2 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.

• Muscle Strain in Multiple Sclerosis Patients Measured by Ultrasound Speckle Tracking TechniqueCompletedNCT03847545Not applicable
• Control Versus Liberal Cardiac Frequency in Patients in Sepse With Atrial Fibrillation of High Ventricular ResponseStatus unknownNCT03715556Phase 3
• 4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic ProstatectomyWithdrawnNCT03658408Phase 2
• 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular MigraineWithdrawnNCT03578354Phase 2
• Time-dependent Amiodarone Treatment in Atrial FibrillationCompletedNCT03432663Phase 4
• Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)Status unknownNCT03228823Phase 4
• A Trial Testing Amiodarone in Chagas CardiomiopathyStatus unknownNCT03193749Phase 3
• Propafenone Versus Amiodarone in Septic ShockCompletedNCT03029169Phase 4
• Catheter Ablation Versus Amiodarone for Therapy of Premature Ventricular Contractions in Patients With Structural Heart DiseaseCompletedNCT02924285Phase 3
• Use of Dalfampridine in Primary Lateral SclerosisCompletedNCT02868567Phase 1
• Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.CompletedNCT02849782Phase 4
• Treatment of Postoperative Atrial Fibrillation - Comparison of Amiodarone and Placebo.Status unknownNCT02715687Phase 3
• Fed-Fasted, Single and Multiple Ascending Dose Trial of XEN-D0103CompletedNCT02390258Phase 1
• AMIOdarone vs. Catheter Ablation for Prevention of Recurrent Symptomatic Atrial FibrillationTerminatedNCT02341105Phase 4
• Catheter Ablation Compared With Pharmacological Therapy for Atrial Fibrillation (CAPTAF Trial)Status unknownNCT02294955Not applicable
• Efficacy of Dalfampridine on Upper Extremity Function in Patients With MSStatus unknownNCT02259361Phase 4
• Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS PatientsCompletedNCT02146534Phase 4
• Antiarrhythmic Drugs Assessment in Preventing Atrial FibrillationStatus unknownNCT02145546Phase 4
• Resistance Training and Amino Pyridine in Multiple SclerosisCompletedNCT02143167Phase 4
• A New Medicine to Treat Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)CompletedNCT01975324Phase 4
• Atrial Fibrillation and By-pass SurgeryStatus unknownNCT01955759Early Phase 1
• A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple SclerosisCompletedNCT01917019Phase 3
• Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot StudyStatus unknownNCT01850277Phase 4
• Safety and Efficacy of Oral Versus Intravenous Amiodarone in the Treatment of AFStatus unknownNCT01817439Phase 3
• Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of DeathStatus unknownNCT01722942Not applicable
• Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?CompletedNCT01667497Phase 2/3
• FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of FampyraCompletedNCT01656148Phase 4
• Combination Therapy With Dalfampridine and Locomotor Training for Chronic, Motor Incomplete Spinal Cord InjuryCompletedNCT01621113Phase 2
• Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.CompletedNCT01597297Phase 2
• 4-Aminopyridine in Episodic Ataxia Type 2WithdrawnNCT01543750Phase 2
• The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) PilotCompletedNCT01480336Not applicable
• Pilot Study on the Usefulness of 3,4-diaminopyridine in the Treatment of BotulismCompletedNCT01441557Phase 2/3
• Amiodarone Compared to Dronedarone , Post Cardioversion Maintenance of Sinus RhythmStatus unknownNCT01266681Not applicable
• Open Label Extension Study to Evaluate the Safety and Tolerability of Oral Fampridine-Sustained Release (SR) in Canadian Participants With Multiple Sclerosis Who Participated in Acorda Extension Trials.CompletedNCT01235221Phase 3
• A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy VolunteersCompletedNCT01215084Phase 1
• Effect of Amiodarone on the Procedure Outcome in Long-standing Persistent Atrial Fibrillation Undergoing Pulmonary Vein Antral IsolationCompletedNCT01173809Phase 3
• Ventricular Tachycardia (VT) Ablation or Escalated Drug TherapyCompletedNCT00905853Phase 4
• The Effect of Short Term Amiodarone Treatment After Catheter Ablation for Atrial FibrillationCompletedNCT00826826Not applicable
• Intravenous Metoprolol Versus Intravenous Amiodarone in the Prevention of Atrial Fibrillation After Cardiac SurgeryCompletedNCT00784316Phase 4
• A Randomized, Placebo-Controlled, Double-Blind, Double Dummy Trial To Determine The Relative Effect Of Pm101 Versus Placebo And Amiodarone IV On Blood Pressure In Subjects With Stable Congestive Heart FailureWithdrawnNCT00739193Phase 2
• Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICDCompletedNCT00729911Phase 4
• Amiodarone Prophylaxis for Atrial Fibrillation in Patients Undergoing Surgery for Lung CancerStatus unknownNCT00724581Phase 4
• DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada SyndromeTerminatedNCT00701077Phase 3
• Relative Bioavailability of PM101 IV and Cordarone IVCompletedNCT00420953Phase 1
• Continuous Versus Episodic Amiodarone Treatment for the Prevention of Permanent Atrial FibrillationCompletedNCT00392431Not applicable
• Iv Amiodarone Versus Iv Procainamide to Treat Haemodynamically Well Tolerated Ventricular TachycardiaTerminatedNCT00383799Phase 4
• Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic StimulationCompletedNCT00342381Phase 2
• Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)CompletedNCT00287209Phase 4
• Radiofrequency Catheter Ablation for Chronic Atrial FibrillationCompletedNCT00272636Not applicable
• Amiodarone to Prevent Post-Operative ArrhythmiasCompletedNCT00251706Phase 3
• Efficacy of 3,4-DAP in Fatigue Associated With Multiple SclerosisCompletedNCT00190268Phase 3
• Assessment of Chronic Guillain-Barre Syndrome Improvement With Use of 4-aminopyridineCompletedNCT00056810Phase 2
• Comparing the Effects of Amiodarone, Sotalol, and Placebo in Maintaining Sinus Rhythm in Patients With Atrial Fibrillation Converted to Sinus RhythmCompletedNCT00007605Phase 3
• Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic SyndromeCompletedNCT00004832Not applicable
• Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)CompletedNCT00000609Phase 3
• Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)CompletedNCT00000464Phase 3

← Potassium channel blockers overview